Robin Kahn
21 – 30 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis
(
- Contribution to journal › Article
- 2017
-
Mark
Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis
(
- Contribution to journal › Article
-
Mark
Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
C1-inhibitor decreases the release of vasculitis-like chemotactic endothelial microvesicles
(
- Contribution to journal › Article
-
Mark
Endothelial dysfunction is associated with activation of the type I interferon system and platelets in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
G protein-coupled Estrogen Receptor 1 (GPER1)/GPR30 Increases ERK1/2 Activity Through PDZ-dependent and -independent Mechanisms
(
- Contribution to journal › Article
- 2016
-
Mark
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
(
- Contribution to journal › Article
-
Mark
G protein-coupled Receptor 30 (GPR30) PDZ-dependently and Constitutively Increases ERK1/2 Signaling Through Calcineurin and Kinase Suppressor of Ras 2 (KSR2)
(
- Contribution to journal › Published meeting abstract
-
Mark
Platelet-derived S100A8/A9 and cardiovascular disease in systemic lupus erythematosus.
2016) In Arthritis & Rheumatology(
- Contribution to journal › Article
- 2015
-
Mark
Idiopathic Angioedema and Urticarial Vasculitis in a Patient with a History of Acquired Haemophilia.
(
- Contribution to journal › Article